title: Point: Is an increase in FEV₁ and/or FVC ≥ 12% of control and ≥ 200 mL the best way to assess positive bronchodilator response? Yes.
authors.affiliation: The Allergologia e Fisiopatologia Respiratoria, Scuola di Scienze Mediche e Farmaceutiche, Università di Genova, Cuneo, Italy. Electronic address: pellegrino.r@ospedale.cuneo.it.
authors.forename: Riccardo
authors.initials: R
authors.lastname: Pellegrino
authors.affiliation: Dipartimento di Medicina Interna e Specialità Mediche, Scuola di Scienze Mediche e Farmaceutiche, Università di Genova, Genova, Italy.
authors.forename: Vito
authors.initials: V
authors.lastname: Brusasco
mesh_terms: D001249:Asthma / Q000175:diagnosis / Q000503:physiopathology; D001993:Bronchodilator Agents / Q000494:pharmacology*; D003937:Diagnosis, Differential; D005541:Forced Expiratory Volume / Q000502:physiology*; D006801:Humans; D008168:Lung / Q000187:drug effects* / Q000502:physiology*; D029424:Pulmonary Disease, Chronic Obstructive / Q000175:diagnosis / Q000503:physiopathology; D012129:Respiratory Function Tests; D012680:Sensitivity and Specificity; D013147:Spirometry; D014797:Vital Capacity / Q000502:physiology*
chemical_list: D001993:Bronchodilator Agents